+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biofilm Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Product Coverage, Wound Coverage, End User Coverage, Geographic Coverage and By Company)

  • PDF Icon

    Report

  • 180 Pages
  • May 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5976417
The global biofilm treatment market is on an upward trajectory, with projections indicating a growth from $1.5 billion in 2023 to $2.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.2%. This robust growth is driven by various factors, including the increasing demand for biodegradable packaging, expansion of key industries, and technological advancements.

Key Growth Determinants

Environmental Sustainability and Biodegradability

The global shift towards environmental sustainability is a primary driver for the biofilm treatment market. As the world increasingly focuses on reducing environmental impact, the demand for biodegradable and eco-friendly packaging solutions has surged. Biofilm treatment, particularly biodegradable carton-board packaging, aligns perfectly with this trend, offering total biodegradability and catering to the preferences of environmentally conscious consumers.

Expansion of the FMCG Industry

The fast-moving consumer goods (FMCG) sector is experiencing rapid growth, further fueling the biofilm treatment market. The FMCG industry’s demand for efficient and reliable packaging solutions positions biofilm treatment as a critical component in supporting the sector’s dynamic evolution. Biofilm treatment solutions are extensively used in this industry to meet diverse packaging needs.

Technological Advancements and Automation

Technological advancements and the increasing trend towards automation are significant drivers of the biofilm treatment market. The shift towards automatic biofilm treatment is propelled by the benefits of enhanced productivity, cost-effectiveness, and improved product quality and safety. Automation in the 10 to 25 CPM category is particularly vital for industries with moderate production quantities, ensuring a balance between speed and precision.

Major Growth Barriers

Technological Complexity and Implementation Challenges

The technological complexity of advanced biofilm treatments presents a barrier to market growth. Implementing sophisticated biofilm treatment solutions requires substantial investments in training and system integration, posing challenges for smaller businesses. Overcoming these implementation hurdles is crucial to unlocking the market’s full potential.

Regulatory Compliance and Certification

Stringent regulatory compliance and certification requirements act as significant restraints in the biofilm treatment market. Meeting the standards for bio-based and biodegradable packaging demands rigorous testing and verification processes, which can be time-consuming and costly. Streamlining certification processes and establishing clear industry standards are essential to mitigate these challenges and foster market growth.

Key Trends and Opportunities

Surge in Sustainable Packaging

The global trend towards sustainable packaging is robust, with biofilm treatment gaining prominence for its biodegradability. This trend is driven by environmental consciousness, with key companies developing bio-based solutions and investing in eco-friendly initiatives. Brands are leveraging sustainable packaging to enhance their environmental credentials and meet the rising consumer demand for green products.

Integration of Smart Technologies

The integration of smart technologies within biofilm treatment is experiencing rapid growth. Companies are incorporating sensors and QR codes for enhanced functionality, improving traceability and quality control. Smart packaging innovations provide heightened supply chain visibility, product authenticity, and improved consumer engagement, responding to the global demand for intelligent packaging solutions.

Customization and Versatility

Customization and versatility in biofilm treatment are gaining momentum. Companies are developing treatments that address diverse packaging requirements, with flexible solutions adaptable to changing market demands. Brands leverage customization to differentiate their products, cater to specific consumer preferences, and maintain agility in responding to evolving market dynamics.

Regional Frontrunners

  • North America: Advanced Healthcare Infrastructure and High Awareness
North America stands as the largest regional market in the global biofilm treatment market. The region’s dominance is attributed to its advanced healthcare infrastructure, high awareness levels regarding sustainable practices, and a significant prevalence of chronic diseases. The US, in particular, plays a pivotal role, boasting robust research and development activities, substantial healthcare expenditure, and a strong presence of key industry players.
  • Asia Pacific: Rapid Growth and Government Initiatives
The Asia Pacific region is emerging as the fastest-growing market in the global biofilm treatment market. Factors driving this rapid growth include increasing healthcare investments, a burgeoning population with diverse healthcare needs, and heightened awareness of advanced wound care solutions. Government initiatives promoting sustainable packaging align with market trends, fostering growth. Key players are expanding their presence and adapting strategies to cater to the unique demands of the Asia Pacific market.

Competitive Analysis

1. Novozymes A/S
2. 3M Company
3. Pfizer Inc.
4. Merck & Co. Inc.
5. Sanofi
6. Biofilm Inc.
7. ConvaTec Group PLC
8. Abbott Laboratories
9. BioGaia AB
10. Kane Biotech Inc.
11. Others

Global Biofilm Treatment Market is Segmented as Below:

By Product:

  • Gauze
  • Dressing
  • Ointment
  • Gel
  • Others

By Wound:

  • Diabetic Foot Ulcer
  • Traumatic and Surgical Wounds
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Burns and Other Open Wounds

By End User:

  • Hospital
  • Ambulatory Surgical Centres
  • Wound Care Centres
  • Others

By Geographic Coverage:

  • North America
  • S.
  • Canada
  • Europe
  • Germany
  • K.
  • France
  • Italy
  • Turkey
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Egypt
  • Nigeria
  • Rest of Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Biofilm Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Biofilm Treatment Market Outlook, 2018 - 2030
3.1. Global Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Gauze
3.1.1.2. Dressing
3.1.1.3. Ointment
3.1.1.4. Gel
3.1.1.5. Others
3.2. Global Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Diabetic Foot Ulcer
3.2.1.2. Traumatic and Surgical Wounds
3.2.1.3. Pressure Ulcers
3.2.1.4. Venous Leg Ulcers
3.2.1.5. Burns and Other Open Wounds
3.3. Global Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Hospital
3.3.1.2. Ambulatory Surgical Centres
3.3.1.3. Wound Care Centres
3.3.1.4. Others
3.4. Global Biofilm Treatment Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Biofilm Treatment Market Outlook, 2018 - 2030
4.1. North America Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Gauze
4.1.1.2. Dressing
4.1.1.3. Ointment
4.1.1.4. Gel
4.1.1.5. Others
4.2. North America Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Diabetic Foot Ulcer
4.2.1.2. Traumatic and Surgical Wounds
4.2.1.3. Pressure Ulcers
4.2.1.4. Venous Leg Ulcers
4.2.1.5. Burns and Other Open Wounds
4.3. North America Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Hospital
4.3.1.2. Ambulatory Surgical Centres
4.3.1.3. Wound Care Centres
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
4.4.1.2. U.S. Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
4.4.1.3. U.S. Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
4.4.1.4. U.S. Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
4.4.1.5. Canada Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
4.4.1.6. Canada Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
4.4.1.7. Canada Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
4.4.1.8. Canada Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Biofilm Treatment Market Outlook, 2018 - 2030
5.1. Europe Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Gauze
5.1.1.2. Dressing
5.1.1.3. Ointment
5.1.1.4. Gel
5.1.1.5. Others
5.2. Europe Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Diabetic Foot Ulcer
5.2.1.2. Traumatic and Surgical Wounds
5.2.1.3. Pressure Ulcers
5.2.1.4. Venous Leg Ulcers
5.2.1.5. Burns and Other Open Wounds
5.3. Europe Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Hospital
5.3.1.2. Ambulatory Surgical Centres
5.3.1.3. Wound Care Centres
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.2. Germany Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.3. Germany Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.4. Germany Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.5. U.K. Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.6. U.K. Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.7. U.K. Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.8. U.K. Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.9. France Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.10. France Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.11. France Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.12. France Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.13. Italy Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.14. Italy Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.15. Italy Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.16. Italy Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.17. Turkey Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.18. Turkey Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.19. Turkey Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.20. Turkey Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.21. Russia Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.22. Russia Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.23. Russia Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.24. Russia Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.1.25. Rest of Europe Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
5.4.1.26. Rest of Europe Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
5.4.1.27. Rest of Europe Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
5.4.1.28. Rest of Europe Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biofilm Treatment Market Outlook, 2018 - 2030
6.1. Asia Pacific Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Gauze
6.1.1.2. Dressing
6.1.1.3. Ointment
6.1.1.4. Gel
6.1.1.5. Others
6.2. Asia Pacific Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Diabetic Foot Ulcer
6.2.1.2. Traumatic and Surgical Wounds
6.2.1.3. Pressure Ulcers
6.2.1.4. Venous Leg Ulcers
6.2.1.5. Burns and Other Open Wounds
6.3. Asia Pacific Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Hospital
6.3.1.2. Ambulatory Surgical Centres
6.3.1.3. Wound Care Centres
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.2. China Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.3. China Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.4. China Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.5. Japan Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.6. Japan Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.7. Japan Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.8. Japan Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.9. South Korea Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.10. South Korea Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.11. South Korea Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.12. South Korea Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.13. India Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.14. India Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.15. India Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.16. India Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.17. Southeast Asia Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.18. Southeast Asia Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.19. Southeast Asia Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.20. Southeast Asia Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.1.21. Rest of Asia Pacific Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
6.4.1.22. Rest of Asia Pacific Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
6.4.1.23. Rest of Asia Pacific Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
6.4.1.24. Rest of Asia Pacific Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biofilm Treatment Market Outlook, 2018 - 2030
7.1. Latin America Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Gauze
7.1.1.2. Dressing
7.1.1.3. Ointment
7.1.1.4. Gel
7.1.1.5. Others
7.2. Latin America Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Diabetic Foot Ulcer
7.2.1.2. Traumatic and Surgical Wounds
7.2.1.3. Pressure Ulcers
7.2.1.4. Venous Leg Ulcers
7.2.1.5. Burns and Other Open Wounds
7.3. Latin America Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Hospital
7.3.1.2. Ambulatory Surgical Centres
7.3.1.3. Wound Care Centres
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.2. Brazil Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.3. Brazil Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.4. Brazil Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.1.5. Mexico Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.6. Mexico Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.7. Mexico Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.8. Mexico Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.1.9. Argentina Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.10. Argentina Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.11. Argentina Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.12. Argentina Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.1.13. Rest of Latin America Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
7.4.1.14. Rest of Latin America Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
7.4.1.15. Rest of Latin America Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
7.4.1.16. Rest of Latin America Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biofilm Treatment Market Outlook, 2018 - 2030
8.1. Middle East & Africa Biofilm Treatment Market Outlook, by Product, Value (US$ Mn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Gauze
8.1.1.2. Dressing
8.1.1.3. Ointment
8.1.1.4. Gel
8.1.1.5. Others
8.2. Middle East & Africa Biofilm Treatment Market Outlook, by Wound, Value (US$ Mn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Diabetic Foot Ulcer
8.2.1.2. Traumatic and Surgical Wounds
8.2.1.3. Pressure Ulcers
8.2.1.4. Venous Leg Ulcers
8.2.1.5. Burns and Other Open Wounds
8.3. Middle East & Africa Biofilm Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Hospital
8.3.1.2. Ambulatory Surgical Centres
8.3.1.3. Wound Care Centres
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Biofilm Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.2. GCC Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.3. GCC Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.4. GCC Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.5. South Africa Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.6. South Africa Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.7. South Africa Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.8. South Africa Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.9. Egypt Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.10. Egypt Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.11. Egypt Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.12. Egypt Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.13. Nigeria Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.14. Nigeria Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.15. Nigeria Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.16. Nigeria Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.1.17. Rest of Middle East & Africa Biofilm Treatment Market by Product, Value (US$ Mn), 2018 - 2030
8.4.1.18. Rest of Middle East & Africa Biofilm Treatment Market Wound, Value (US$ Mn), 2018 - 2030
8.4.1.19. Rest of Middle East & Africa Biofilm Treatment Market End User, Value (US$ Mn), 2018 - 2030
8.4.1.20. Rest of Middle East & Africa Biofilm Treatment Market End Use, Value (US$ Mn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. End User vs Application Heatmap
9.2. Manufacturer vs Application Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. BluePrint Wound
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Novozymes A/S
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. 3M Company
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Pfizer Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Merck & Co. Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Sanofi
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Biofilm Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. ConvaTec Group PLC
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Abbott Laboratories
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. BioGaia AB
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Kane Biotech Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Others
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Novozymes A/S
  • 3M Company
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi
  • Biofilm Inc.
  • ConvaTec Group PLC
  • Abbott Laboratories
  • BioGaia AB
  • Kane Biotech Inc.

Methodology

Loading
LOADING...